These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview. Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895 [TBL] [Abstract][Full Text] [Related]
45. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714 [TBL] [Abstract][Full Text] [Related]
46. Linkage analysis of families with autosomal dominant polycystic kidney disease by KG8-CA marker. Yuan CF; Lin CY; Chen TW; Yang ML; Ng HT Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):125-9. PubMed ID: 9419947 [TBL] [Abstract][Full Text] [Related]
49. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433 [TBL] [Abstract][Full Text] [Related]
50. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Reddy BV; Chapman AB Pediatr Nephrol; 2017 Jan; 32(1):31-42. PubMed ID: 27034070 [TBL] [Abstract][Full Text] [Related]
51. Genetics and Autosomal Dominant Polycystic Kidney Disease Progression. Corradi V; Giuliani A; Gastaldon F; de Cal M; Mancini B; Montaldi A; Alghisi A; Capelli I; La Manna G; Ronco C Contrib Nephrol; 2017; 190():117-123. PubMed ID: 28535524 [TBL] [Abstract][Full Text] [Related]
52. Is autosomal dominant polycystic kidney disease an early sweet disease? Dachy A; Decuypere JP; Vennekens R; Jouret F; Mekahli D Pediatr Nephrol; 2022 Sep; 37(9):1945-1955. PubMed ID: 34988697 [TBL] [Abstract][Full Text] [Related]
53. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease. Xu Y; Li A; Wu G; Liang C Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735 [TBL] [Abstract][Full Text] [Related]
54. Liver cysts in Congolese patients with autosomal dominant polycystic kidney disease follow a family pattern. Assounga AG; Yacoubou Y; Makosso E; Ibara JR; Gombet T S Afr Med J; 2003 Jul; 93(7):542-4. PubMed ID: 12939930 [TBL] [Abstract][Full Text] [Related]
55. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial. Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108 [TBL] [Abstract][Full Text] [Related]
56. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model. McEwan P; Bennett Wilton H; Ong ACM; Ørskov B; Sandford R; Scolari F; Cabrera MV; Walz G; O'Reilly K; Robinson P BMC Nephrol; 2018 Feb; 19(1):37. PubMed ID: 29439650 [TBL] [Abstract][Full Text] [Related]
57. New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. Yang B; Chen S; Yang G; Mei C; Ong A; Mao Z BMJ Open; 2015 Nov; 5(11):e008440. PubMed ID: 26546139 [TBL] [Abstract][Full Text] [Related]
58. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease. Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168 [TBL] [Abstract][Full Text] [Related]
59. Volume Reduction in Enlarged Kidneys in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Prior to Renal Transplant with Transcatheter Arterial Embolization (TAE): A Systematic Review and Meta-Analysis. Ye W; Voss MD; Athreya S Cardiovasc Intervent Radiol; 2018 Jun; 41(6):828-834. PubMed ID: 29388019 [TBL] [Abstract][Full Text] [Related]
60. The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View. Guarnaroli M; Padoan F; Fava C; Benetti MG; Brugnara M; Pietrobelli A; Piacentini G; Pecoraro L Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]